Table 3. Linkage disequilibrium of DR/DQ susceptibility epitopes in type 1 diabetes patients and control subjects.
HLA class II susceptibility epitopes | Patients (%) (N = 170) | Control subjects (%) (N = 192) | P Value | OR (95% CI) | LD in patients P value (OR) | LD in controls P value (OR) |
---|---|---|---|---|---|---|
DRβ Q70+/DQβ A57+ | 153 (90) | 57 (29.7) | ≤ 0.0001 | 21.3 (11.8–38.4) | 0.001 (20.5) | 1.80x10-6 (4.9) |
DRβ Q70+/DQβ A57- | 5 (2.9) | 40 (20.8) | ≤ 0.0001 | 0.1 (0.04–0.3) | ||
DRβ Q70-/DQβ A57+ | 7 (4.1) | 21 (10.9) | 0.02 | 0.35 (0.14–0.84) | ||
DRβ Q70-/DQβ A57- | 5 (2.9) | 74 (38.5) | ≤ 0.0001 | 0.05 (0.02–0.12) |
n (%) p value Fisher exact test